AR015966A1 - Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito - Google Patents

Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito

Info

Publication number
AR015966A1
AR015966A1 ARP980105131A ARP980105131A AR015966A1 AR 015966 A1 AR015966 A1 AR 015966A1 AR P980105131 A ARP980105131 A AR P980105131A AR P980105131 A ARP980105131 A AR P980105131A AR 015966 A1 AR015966 A1 AR 015966A1
Authority
AR
Argentina
Prior art keywords
preparation
pde4 inhibitor
treatment
prurite
inhibitor compound
Prior art date
Application number
ARP980105131A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR015966A1 publication Critical patent/AR015966A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980105131A 1997-10-17 1998-10-15 Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito AR015966A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17

Publications (1)

Publication Number Publication Date
AR015966A1 true AR015966A1 (es) 2001-05-30

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105131A AR015966A1 (es) 1997-10-17 1998-10-15 Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito

Country Status (18)

Country Link
EP (1) EP1030666A4 (de)
JP (1) JP2001520196A (de)
KR (1) KR20010031149A (de)
CN (1) CN1306426A (de)
AR (1) AR015966A1 (de)
AU (1) AU740875B2 (de)
BR (1) BR9814080A (de)
CA (1) CA2306985A1 (de)
CO (1) CO4810374A1 (de)
CZ (1) CZ20001376A3 (de)
HU (1) HUP0003792A3 (de)
IL (1) IL135581A0 (de)
NO (1) NO20001847L (de)
NZ (1) NZ503551A (de)
PL (1) PL341062A1 (de)
TR (1) TR200001040T2 (de)
WO (1) WO1999020280A1 (de)
ZA (1) ZA989450B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60113731T2 (de) 2001-01-31 2006-06-29 Pfizer Products Inc., Groton Als inhibitoren von pde4-isozymen geeignete etherderivate
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
KR20030072614A (ko) 2001-01-31 2003-09-15 화이자 프로덕츠 인크. Ｐｄｅ４ 이소자임 억제제로 유용한 티아졸릴-,옥사졸릴-, 피롤릴- 및 이미다졸릴-산 아미드 유도체
CA2436535A1 (en) 2001-01-31 2002-08-08 Prizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
US20060258703A1 (en) * 2003-07-17 2006-11-16 Ono Pharmaceutical Co., Ltd. Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
JP5001012B2 (ja) 2004-02-14 2012-08-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Ｈｍ７４ａ受容体活性を有する薬剤
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
EP2272848B1 (de) 2005-08-10 2012-12-26 Glaxosmithkline LLC Xanthinderivate als selektive HM74A-Agonisten
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2007218725B2 (en) * 2006-02-21 2011-12-01 Eisai R & D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
EP2202229B1 (de) 2007-08-17 2012-03-14 Eisai R&D Management Co., Ltd. Neue zubereitung für die äusserliche anwendung
ATE538102T1 (de) 2007-08-17 2012-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung eines chinazolinderivats
ES2659458T3 (es) 2011-06-28 2018-03-15 Mitsubishi Tanabe Pharma Corporation Compuestos de naftaleno para tratar el prurito
WO2016119570A1 (zh) 2015-01-30 2016-08-04 上海珊顿医药科技有限公司 尿酸性或痛风性疾病的预防或治疗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098846A1 (en) * 1990-12-21 1992-06-22 David G. Smith Xanthine derivatives
SI0889886T1 (en) * 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
PT912568E (pt) * 1996-05-15 2003-04-30 Altana Pharma Ag Imidazopiridinas
SI0968211T1 (en) * 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
SK122199A3 (en) * 1997-03-18 2000-12-11 Basf Ag Methods and compositions for modulating responsiveness to corticosteroids
DK0988302T3 (da) * 1997-06-03 2003-06-02 Altana Pharma Ag Benzonaphthyridiner

Also Published As

Publication number Publication date
HUP0003792A2 (hu) 2001-10-28
NO20001847D0 (no) 2000-04-10
IL135581A0 (en) 2001-05-20
JP2001520196A (ja) 2001-10-30
NO20001847L (no) 2000-04-10
EP1030666A1 (de) 2000-08-30
NZ503551A (en) 2002-05-31
ZA989450B (en) 1999-04-19
PL341062A1 (en) 2001-03-26
KR20010031149A (ko) 2001-04-16
AU1093899A (en) 1999-05-10
EP1030666A4 (de) 2002-10-16
CO4810374A1 (es) 1999-06-30
TR200001040T2 (tr) 2001-01-22
BR9814080A (pt) 2000-09-26
WO1999020280A1 (en) 1999-04-29
CA2306985A1 (en) 1999-04-29
HUP0003792A3 (en) 2001-12-28
CN1306426A (zh) 2001-08-01
CZ20001376A3 (cs) 2002-06-12
AU740875B2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AR015966A1 (es) Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
BR0108584A (pt) Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
BR0111034A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids
ES2149264T3 (es) Agente terapeutico para el tratamiento de melanomas.
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
BR0107869A (pt) Composições farmacêuticas eletrogiradas
YU49315B (sh) Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
BRPI0308663B8 (pt) uso de inibidores de il-18 para o tratamento e/ou prevenção de doenças vasculares periféricas
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
DE69906963D1 (de) Efavirenz enthaltende gepresste tablettenformulierug
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
MXPA03010672A (es) Composicion para el tratamiento regenerativo de enfermedades del cartilago.
EE200100188A (et) Optiliselt aktiivne püridüül-4H-1,2,4-oksadiasiini derivaat ja selle kasutamine vaskulaarsete haiguste ravis
AR038858A1 (es) Combinacion
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient

Legal Events

Date Code Title Description
FA Abandonment or withdrawal